Share on LinkedInShare on LinkedIn

ARTICLE · 04 FEBRUARY 2016

Federal Circuit Patent Updates - January 2016

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

Federal Circuit Patent Updates - January 2016

United StatesIntellectual Property

View previous updates...

Purdue Pharma L.P. v. Epic Pharma, LLC (No. 2014-1294, 2/3/16) (Prost, Reyna, Stark)

February 1, 2016 9:22 AM

Prost, J. Affirming finding that formulation patents were obvious and anticipated in Hatch-Waxman case. With respect to one patent, the district court correctly disregarded process limitations in a product by process claim when evaluating obviousness. With respect to a second patent, testing showed a claim limitation was inherent in the prior art reference, and the district court did not improperly combine discrete disclosures of the prior art reference.

A full version of the text is available in PDF form.

Akzo Nobel Coatings, Inc. v. Dow Chemical Company (No. 2015-1331, 2015-1389, 1/29/16) (Lourie, Reyna, Chen)

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from